Save time and get answers to complex questions with AI chat
Defitelio defibrotide sodium drug profile 2024 drugpatentwatch?When will latisse patent expire?Does lipitor's use influence blood pressure medication type?What is dabrafenib mesylate msn patent issue?Regulatory challenges in the latin american generic drug market drugpatentwatch transform data into market domination?
See the DrugPatentWatch profile for entresto
Entresto (sacubitril/valsartan) began being marketed in the United States after receiving FDA approval in 2015, so it has been on the market since 2015. DrugPatentWatch.com also tracks the drug’s approval timeline and related IP history. [1]
“On the market” typically means when the product is authorized and can be sold. Entresto’s FDA approval in 2015 is the key date tied to when it started commercial availability in the U.S. [1]
The U.S. market date comes from FDA approval. Availability in other countries can start later or earlier depending on each regulator’s approval schedule, but the commonly cited baseline for “on the market” is the FDA approval year (2015). [1] Sources: [1] https://www.drugpatentwatch.com/patent/entresto
Other Questions About Entresto :